Late Gadolinium Enhancement Amount as an Independent Risk Factor for the Incidence of Adverse Cardiovascular Events in Patients with Stage C or D Heart Failure
Background Myocardial fibrosis (MF) is a risk factor for poor prognosis in dilated cardiomyopathy (DCM). Late gadolinium enhancement (LGE) of the myocardium on cardiac magnetic resonance (CMR) represents MF. We examined whether the LGE amount increases the incidence of adverse cardiovascular events...
Main Authors: | Tong Liu, Xiaohai Ma, Wei Liu, Shukuan Ling, Lei Zhao, Lei Xu, Deli Song, Jie Liu, Zhonghua Sun, Zhanming Fan, Taiyang luo, Junping Kang, Xiaohui Liu, Jianzeng Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-10-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00484/full |
Similar Items
-
Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure
by: Tong Liu, et al.
Published: (2017-04-01) -
Toxicity associated with gadolinium-based contrast-enhanced examinations
by: Silvia Maria Lattanzio
Published: (2021-05-01) -
Modeling of factors affecting late gadolinium enhancement kinetics in MRI of cardiac amyloid
by: Leon Axel
Published: (2023-08-01) -
Late gadolinium enhancement characteristics in giant cell myocarditis
by: Shujuan Yang, et al.
Published: (2021-06-01) -
Late-gadolinium enhancement in a subject with normal left ventricular function
by: Ikuo Misumi, MD, et al.
Published: (2020-11-01)